Columbus Macro LLC Sells 427 Shares of UnitedHealth Group Incorporated $UNH

Columbus Macro LLC decreased its stake in UnitedHealth Group Incorporated (NYSE:UNH) by 6.0% during the 2nd quarter, HoldingsChannel.com reports. The fund owned 6,714 shares of the healthcare conglomerate’s stock after selling 427 shares during the period. Columbus Macro LLC’s holdings in UnitedHealth Group were worth $2,095,000 as of its most recent filing with the SEC.

Several other hedge funds have also added to or reduced their stakes in the stock. Values Added Financial LLC raised its position in UnitedHealth Group by 24.3% in the second quarter. Values Added Financial LLC now owns 1,105 shares of the healthcare conglomerate’s stock worth $345,000 after acquiring an additional 216 shares during the period. Notis McConarty Edward raised its position in shares of UnitedHealth Group by 11.9% in the second quarter. Notis McConarty Edward now owns 8,837 shares of the healthcare conglomerate’s stock valued at $2,757,000 after purchasing an additional 941 shares during the period. Trifecta Capital Advisors LLC raised its position in shares of UnitedHealth Group by 4.9% in the second quarter. Trifecta Capital Advisors LLC now owns 10,360 shares of the healthcare conglomerate’s stock valued at $3,232,000 after purchasing an additional 481 shares during the period. Windle Wealth LLC bought a new stake in shares of UnitedHealth Group in the second quarter valued at approximately $220,000. Finally, Morey & Quinn Wealth Partners LLC raised its position in shares of UnitedHealth Group by 4.5% in the second quarter. Morey & Quinn Wealth Partners LLC now owns 1,778 shares of the healthcare conglomerate’s stock valued at $555,000 after purchasing an additional 77 shares during the period. Institutional investors own 87.86% of the company’s stock.

Analyst Ratings Changes

Several analysts have recently issued reports on the stock. KeyCorp boosted their price target on shares of UnitedHealth Group from $350.00 to $400.00 and gave the company an “overweight” rating in a research report on Wednesday. JPMorgan Chase & Co. reduced their price objective on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating for the company in a research note on Wednesday, August 6th. Wells Fargo & Company boosted their price objective on shares of UnitedHealth Group from $267.00 to $400.00 and gave the company an “overweight” rating in a research note on Tuesday. Oppenheimer reduced their price objective on shares of UnitedHealth Group from $400.00 to $325.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Finally, Barclays boosted their price objective on shares of UnitedHealth Group from $337.00 to $352.00 and gave the company an “overweight” rating in a research note on Thursday, September 4th. Sixteen equities research analysts have rated the stock with a Buy rating, seven have assigned a Hold rating and four have assigned a Sell rating to the company’s stock. According to MarketBeat, UnitedHealth Group presently has a consensus rating of “Hold” and a consensus price target of $372.68.

UnitedHealth Group Price Performance

UNH stock opened at $369.88 on Thursday. The company has a debt-to-equity ratio of 0.73, a current ratio of 0.85 and a quick ratio of 0.85. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73. The stock has a market cap of $334.99 billion, a PE ratio of 16.03, a P/E/G ratio of 2.35 and a beta of 0.47. The firm has a 50 day simple moving average of $313.51 and a two-hundred day simple moving average of $352.54.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings data on Tuesday, July 29th. The healthcare conglomerate reported $4.08 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion during the quarter, compared to analysts’ expectations of $111.75 billion. During the same period last year, the company posted $6.80 EPS. UnitedHealth Group’s revenue for the quarter was up 12.9% on a year-over-year basis. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. On average, analysts predict that UnitedHealth Group Incorporated will post 29.54 EPS for the current fiscal year.

UnitedHealth Group Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Stockholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date of this dividend was Monday, September 15th. This represents a $8.84 dividend on an annualized basis and a dividend yield of 2.4%. UnitedHealth Group’s dividend payout ratio is 38.30%.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.